M
Muin J. Khoury
Researcher at Centers for Disease Control and Prevention
Publications - 523
Citations - 40286
Muin J. Khoury is an academic researcher from Centers for Disease Control and Prevention. The author has contributed to research in topics: Population & Public health. The author has an hindex of 105, co-authored 512 publications receiving 37434 citations. Previous affiliations of Muin J. Khoury include United States Department of Health and Human Services & Université de Montréal.
Papers
More filters
Journal ArticleDOI
Can targeted genetic testing offer useful health information to adoptees
TL;DR: Although genetic analysis is unlikely to provide a replacement for family history when available, if properly targeted and interpreted, such analysis may have the potential to provide useful information regarding health risks when no information currently exists.
Journal ArticleDOI
A Hardy-Weinberg equilibrium test for analyzing population genetic surveys with complex sample designs.
Ramal Moonesinghe,Ajay Yesupriya,Man-Huei Chang,Nicole F. Dowling,Muin J. Khoury,Alastair J Scott +5 more
TL;DR: The authors present a test for Hardy-Weinberg equilibrium that adjusts for the sample weights and correlation of data collected in complex surveys and recommend use of this test when analyzing genetic data originating from sample surveys with complex survey designs to assess deviations from Hardy- weinbergilibrium.
Journal ArticleDOI
Commentary: the affected sib-pair method in the context of an epidemiologic study design.
TL;DR: The purpose of this commentary is to provide a framework for using the well‐known sib‐pair methodology in the context of epidemiologic study designs, using examples from the Pittsburgh family studies of insulin‐dependent diabetes mellitus to illustrate that the sIB‐pair method can be used in family‐based Epidemiologic studies.
Journal ArticleDOI
From genetics to genomics: using gene-based medicine to prevent disease and promote health in children.
TL;DR: An approach to assist pediatricians in decision-making is discussed that emphasizes the need for knowledge about the analytic performance of genetic tests, their validity in predicting health outcomes, and the utility of the genetic information in improving health and preventing disease.
Journal ArticleDOI
Stakeholder assessment of the evidence for cancer genomic tests: insights from three case studies
Patricia A. Deverka,Sheri D. Schully,Naoko Ishibe,Josh J. Carlson,Andrew N. Freedman,Katrina A.B. Goddard,Muin J. Khoury,Scott D. Ramsey +7 more
TL;DR: Stakeholders’ assessment of the current evidence base for clinical practice and coverage decisions should be a critical step in influencing research, policy, and practice.